AI assistant
Edgewise Therapeutics, Inc. — Director's Dealing 2021
Mar 26, 2021
31829_dirs_2021-03-25_615ffee9-1308-46c6-916f-b3491acd2898.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Edgewise Therapeutics, Inc. (EWTX)
CIK: 0001710072
Period of Report: 2021-03-25
Reporting Person: Edris Badreddin (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 19820 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.39 | 2028-04-26 | Common Stock (13960) | Direct | |
| Stock Option (Right to Buy) | $0.64 | 2029-11-14 | Common Stock (17236) | Direct | |
| Stock Option (Right to Buy) | $0.71 | 2030-09-01 | Common Stock (7605) | Direct | |
| Stock Option (Right to Buy) | $1.93 | 2030-12-15 | Common Stock (10463) | Direct | |
| Stock Option (Right to Buy) | $1.93 | 2031-02-03 | Common Stock (66477) | Direct |
Footnotes
F1: 1/4th of the shares subject to the option became vested and exercisable on March 4, 2018 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.
F2: 1/48th of the shares subject to the option became vested and exercisable on November 16, 2019 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.
F3: 1/48th of the shares subject to the option became vested and exercisable on October 2, 2020 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.
F4: 1/48th of the shares subject to the option became vested and exercisable on January 3, 2021 and 1/48th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.
F5: The shares of Common Stock underlying the option are subject to an early exercise provision and are immediately exercisable. 1/36th of the shares subject to the option will become vested on March 3, 2021 and 1/36th of the shares subject to the option continue to vest each month thereafter, subject to the Reporting Person continuing as a service provider through each vest date.